Opportunity Information: Apply for CDC RFA DD12 1208
Apply for CDC RFA DD12 1208
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.184 Disabilities Prevention.
- This funding opportunity was created on Apr 5, 2012 and posted on Apr 5, 2012.
- Applicants must submit their applications by Jun 4, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $150,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD) (Funding Opportunity Number: CDC RFA DD12-1208) was a CDC discretionary grant opportunity offered through a cooperative agreement mechanism, meaning the awardees would be expected to work closely with CDC rather than operate entirely independently. The focus was specifically on non-research activities: the program was designed to fund the creation of a practical, actionable plan to evaluate whether people living with Duchenne muscular dystrophy are receiving health care treatments and services in line with the published DMD Care Considerations, which serve as widely used clinical recommendations for managing DMD across stages of disease.
The core objective of the opportunity was not to directly deliver medical care or to run clinical trials, but to lay the groundwork for measuring real-world adherence to recommended care. In plain terms, CDC wanted recipients to map out how one could systematically check whether recommended DMD-related services and treatments are actually reaching patients as intended. This includes thinking through what data sources would be used, what measures or indicators would best reflect guideline-consistent care, how evaluation would be implemented, and what stakeholders (clinicians, families, care centers, registries, insurers, health systems, advocacy groups, and others) would need to be engaged to make the evaluation credible and feasible.
Funding was limited and relatively small, reflecting the planning nature of the work. CDC expected to make up to three awards, with an estimated total funding amount of $150,000 and an award ceiling of $150,000 (the award floor was listed as $0). There was no cost sharing or matching requirement, which lowered the barrier to participation for organizations that might not have extra funds to contribute. The program was categorized under Health, with CFDA number 93.184 (Disabilities Prevention), aligning it with public health efforts to understand and improve services for individuals with disabilities and chronic conditions.
Eligibility was described as unrestricted, meaning the competition was broadly open to any type of entity, subject to any additional eligibility details that may have appeared in the full announcement text. This kind of open eligibility commonly allows applications from a wide range of organizations such as universities, nonprofits, medical centers, professional associations, and potentially certain private entities, provided they can demonstrate the capacity to carry out the planning and coordination work required.
Key administrative details place the opportunity in 2012. It was posted and created on April 5, 2012, with an original and current closing date of June 4, 2012, and it was archived on July 4, 2012. For applicants who had trouble accessing the full announcement, CDC directed inquiries to the Procurement and Grants Office, Technical Information and Management Section (TIMS), with a listed phone number for general submission questions.
Overall, the grant opportunity can be understood as a targeted CDC effort to strengthen accountability and quality improvement in DMD care by supporting a structured evaluation plan. The intended end product was likely a blueprint that could later be used to assess gaps in care delivery, identify where guideline-based services are not consistently provided, and inform future public health or health system actions aimed at improving adherence to the DMD Care Considerations.
Frequently Asked Questions (FAQs)
What is the name of this funding opportunity?
The opportunity is titled "Developing a Plan to Evaluate Delivery of Health Care Treatments and Services for Duchenne Muscular Dystrophy (DMD)." The Funding Opportunity Number is CDC RFA DD12-1208.
Which federal agency offered this grant?
This was a CDC discretionary grant opportunity offered by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism was used?
The opportunity used a cooperative agreement mechanism. That means awardees were expected to work closely with CDC, rather than operating completely independently.
Was this opportunity intended to fund research or clinical trials?
No. The focus was specifically on non-research activities. The objective was planning work: developing a practical, actionable plan to evaluate real-world delivery of DMD treatments and services against published recommendations.
What was the main purpose of the project funded under this opportunity?
The core purpose was to create a plan for evaluating whether people living with Duchenne muscular dystrophy are receiving health care treatments and services consistent with the published DMD Care Considerations.
What are the "DMD Care Considerations" in the context of this grant?
They are published clinical recommendations that are widely used for managing DMD across stages of disease. This opportunity focused on evaluating whether recommended services and treatments are actually reaching patients in line with those considerations.
What kinds of activities would a funded project be expected to plan for?
Based on the opportunity description, planning would include identifying potential data sources, proposing measures or indicators that reflect guideline-consistent care, outlining how an evaluation could be implemented, and determining which stakeholders would need to be engaged to ensure the evaluation is credible and feasible.
What stakeholders did CDC expect applicants to consider involving in the evaluation plan?
The description highlights stakeholders such as clinicians, families, care centers, registries, insurers, health systems, advocacy groups, and others relevant to DMD care delivery and measurement.
How many awards did CDC expect to make?
CDC expected to make up to three awards.
How much funding was available in total?
The estimated total funding amount was $150,000.
What was the maximum award amount per awardee?
The award ceiling was $150,000.
Was there a minimum award amount?
The award floor was listed as $0.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement.
What program area or category was this opportunity associated with?
The program was categorized under Health.
What CFDA number was associated with this opportunity?
The CFDA number was 93.184 (Disabilities Prevention).
What did "eligibility was unrestricted" mean for applicants?
Eligibility was described as unrestricted, meaning the competition was broadly open to any type of entity, subject to any additional eligibility details that may have appeared in the full announcement text.
What types of organizations might have been able to apply based on the unrestricted eligibility description?
The description suggests the competition could commonly include entities such as universities, nonprofits, medical centers, professional associations, and potentially certain private entities, as long as they could demonstrate the capacity to carry out the planning and coordination work.
When was the opportunity posted?
It was posted (and created) on April 5, 2012.
When was the application closing date?
The original and current closing date was June 4, 2012.
When was the opportunity archived?
It was archived on July 4, 2012.
Where were applicants directed if they had trouble accessing the full announcement?
Applicants were directed to contact the CDC Procurement and Grants Office, Technical Information and Management Section (TIMS) for assistance, and a phone number was listed for general submission questions.
What was the intended end product of the funded work?
The intended end product was a structured, practical "blueprint" or plan that could later be used to assess gaps in DMD care delivery, identify areas where guideline-based services are not consistently provided, and inform future public health or health system actions aimed at improving adherence to the DMD Care Considerations.
Did this opportunity fund direct delivery of medical care?
No. The opportunity was not designed to directly deliver medical care. It was designed to fund planning for evaluating delivery of recommended care in real-world settings.
Browse more opportunities from the same category: Health
Next opportunity: Amargosa Vole Epidemmiology Study
Previous opportunity: Women in Apprenticeship and Nontraditional Occupations (WANTO)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA DD12 1208
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA DD12 1208) also looked into and applied for these:
| Funding Opportunity |
|---|
| Surveillance of Congenital Heart Defects (CHDs) Focusing on Adolescents and Adults Apply for CDC RFA DD12 1207 Funding Number: CDC RFA DD12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $550,000 |
| Short Term Research Education Program to Increase Diversity in Health Related Research (R25) Apply for RFA HL 13 020 Funding Number: RFA HL 13 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Support for Title V/Maternal and Child Health Oral Health Services Grant Program Apply for HRSA 12 059 Funding Number: HRSA 12 059 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Limited Competition Revisions to Existing NIMH Supported Cooperative Agreement Awards (U01) Apply for PAR 12 154 Funding Number: PAR 12 154 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (Nevada Washoe County) Apply for PA FPH 12 028 Funding Number: PA FPH 12 028 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $785,000 |
| Strengthening Surveillance for Diseases Among Newly Arrived Immigrants and Refugees Apply for CDC RFA CK12 1205 Funding Number: CDC RFA CK12 1205 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Continuing the Expansion of the Overseas Health Assessment and Management of U.S. Bound Refugees Apply for CDC RFA CK12 1207 Funding Number: CDC RFA CK12 1207 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Statewide Consumer Network Grant Apply for SM 12 002 Funding Number: SM 12 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Statewide Family Network Program Apply for SM 12 001 Funding Number: SM 12 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Integrative Omics Data Analysis for Discovery in Lung Diseases (R01) Apply for PAR 12 155 Funding Number: PAR 12 155 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Career Transition Award (K22) Apply for PAR 12 156 Funding Number: PAR 12 156 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Implementation of Programs for Care Treatment of HIV/AIDS in the Republic of Mozambique under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1225 Funding Number: CDC RFA GH12 1225 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Research and Technical Assistance for Public Health Interventions in Haiti to support post earthquake reconstruction, cholera and HIV/AIDS Apply for RFA GH 12 001 Funding Number: RFA GH 12 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Clinical Trials Units for NIAID Networks (UM1) Apply for RFA AI 12 018 Funding Number: RFA AI 12 018 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing the Control and Elimination of Neglected Tropical Diseases Apply for CDC RFA GH12 1258 Funding Number: CDC RFA GH12 1258 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Administrative Supplements for Collaborative Science Opportunities for Existing NIDCR Grants and Cooperative Agreements (Admin Supp) Apply for PA 12 159 Funding Number: PA 12 159 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY12 Announcement of Anticipated Availability of Funds for Family Planning Services Grants (North Carolina) Apply for PA FPH 12 029 Funding Number: PA FPH 12 029 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $7,323,350 |
| Collaborative Activities to Promote Research on Integrative Approaches to Symptom Management in Military Populations (Administrative Supplement) Apply for PA 12 160 Funding Number: PA 12 160 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Announcement of Availability of FY 2012 Funds for Cooperative Agreements for Family Planning Research Apply for PA FPR 12 001 Funding Number: PA FPR 12 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
| Cooperative Agreement with the National Center for Disease Control and Public Health (NCDC) of the Republic of Georgia Apply for CDC RFA GH12 1259 Funding Number: CDC RFA GH12 1259 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA DD12 1208", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.